Evan Calio analyst BTIG

Currently out of the existing stock ratings of Evan Calio, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Evan Calio

Work Performance Price Targets & Ratings Chart

Analyst Evan Calio, currently employed at BTIG, carries an average stock price target met ratio of 75% that have a potential upside of 47.65% achieved within 1388 days.

Evan Calio’s has documented 22 price targets and ratings displayed on 4 stocks. The coverage is on the Energy sector.

Most recent stock forecast was given on MRO, Marathon Oil at 21-Jun-2017.

Wall Street Analyst Evan Calio

Analyst best performing recommendations are on MRO (MARATHON OIL).
The best stock recommendation documented was for MRO (MARATHON OIL) at 6/21/2017. The price target of $14 was fulfilled within 135 days with a profit of $3.52 (33.59%) receiving and performance score of 2.49.

Average potential price target upside

CVX Chevron Corp EOG EOG Resources MRO Marathon Oil OXY Occidental Petroleum

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 16-Aug-2023

$206

$50.1 (32.14%)

$204

25 days ago
(12-Dec-2025)

0/22 (0%)

$56.01 (37.34%)

Hold

Since 13-May-2025

$169

$13.1 (8.40%)

$158

1 months 5 days ago
(01-Dec-2025)

1/6 (16.67%)

$17.87 (11.82%)

101

Buy

Since 01-Apr-2021

$168

$12.1 (7.76%)

$169

1 months 24 days ago
(13-Nov-2025)

8/23 (34.78%)

$12.42 (7.98%)

710

Buy

Since 03-Nov-2025

$180

$24.1 (15.46%)

$177

1 months 24 days ago
(13-Nov-2025)

8/24 (33.33%)

$24.42 (15.70%)

331

Buy

Since 21-Oct-2021

$160

$4.1 (2.63%)

$175

2 months 20 days ago
(17-Oct-2025)

3/17 (17.65%)

$6.92 (4.52%)

128

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Evan Calio?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?